Agile Therapeutics Inc

NASDAQ:AGRX  
0.19
0.00 (-0.63%)
7:59:37 PM EDT: $0.19 0.00 (-1.75%)
Earnings Announcements

Agile Therapeutics Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:23 GMT
Agile Therapeutics Inc (AGRX) - Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Agile Therapeutics Inc - Qtrly Revenue $3 Million Versus $1.3 Million.
Agile Therapeutics Inc - Qtrly Loss per Share $0.53.
Revenue is expected to be $3.09 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $2.63 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.